Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.
Impact
If enacted, HCR96 could facilitate a significant shift in how insurance policies address fertility preservation for cancer patients in Hawaii. Currently, many individuals are burdened with the high costs of such procedures, which can exceed $10,000, and find that these options are often unavailable due to insufficient insurance coverage. By mandating coverage, this bill would make necessary healthcare services more attainable and could lead to a broader recognition of fertility preservation as a standard care option within oncology, aligning Hawaii with other states that already offer such coverage.
Summary
HCR96 is a House Concurrent Resolution from the Thirty-Second Legislature of Hawaii, which requests the Auditor to evaluate the social and financial implications of mandating health insurance coverage for fertility preservation procedures for individuals diagnosed with cancer. This bill highlights the issue that certain cancer treatments may impair fertility, and it advocates for the accessibility of these crucial procedures for patients who wish to preserve their ability to conceive after treatment. With rising survival rates among cancer patients, especially those aged zero to forty-five, the demand for fertility preservation is more pronounced than ever.
Contention
Discussions surrounding HCR96 may involve debates over the financial sustainability of insurance mandates and concerns regarding potential implications for insurance premiums and coverage availability. Notably, while supporters emphasize the importance of addressing fertility issues for cancer survivors, skeptics may question whether the mandate appropriately balances health care costs against individual needs. The outcome of the Auditor's assessment may greatly influence the direction of future legislation on this issue, shaping the landscape of reproductive healthcare and insurance coverage in Hawaii.
Same As
Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.
Requesting The Auditor To Conduct A Social And Financial Assessment Of Proposed Mandatory Health Insurance Coverage For Step Therapy Requirements For Stage Two Through Stage Five Cancer.
Requesting The Auditor To Conduct A Social And Financial Assessment Of Proposed Mandatory Health Insurance Coverage For Step Therapy Requirements For Stage Two Through Stage Five Cancer.
Requesting The Auditor To Assess Both The Social And Financial Effects Of Proposed Mandated Health Insurance Coverage For A Percentage Of The Costs Of Ketamine Therapy To Treat Depression And Suicide Ideation.
Requesting The Auditor To Assess Both The Social And Financial Effects Of Proposed Mandated Health Insurance Coverage For A Percentage Of The Costs Of Ketamine Therapy To Treat Depression And Suicide Ideation.
Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.
Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.
Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.
Provides relative to mandatory drug testing, screening, and assessment for drug and specialty court participation for certain offenders (Item #10) (REF SEE FISC NOTE LF EX See Note)